Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01988454 · ClinicalTrials.gov registry record
Characterization of Dyslipidemia in Adolescent Obesity
A clinical trial, sponsored by Health Diagnostic Laboratory.
- Completed
- Registry status
- 50
- Enrollment target
NCT01988454: Completed study, sponsored by Health Diagnostic Laboratory.
NCT01988454 is a clinical trial that has completed, run by Health Diagnostic Laboratory. The registered enrollment target is 50 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01988454 has completed, sponsored by Health Diagnostic Laboratory.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
Study Summary
The primary objective of this pilot study is to characterize the profile of lipoprotein, inflammatory, and metabolic markers of cardiovascular disease in obese adolescents as compared to normal-weight age-matched controls.
Primary Outcome
To characterize and compare lipoprotein, inflammation and metabolic markers in obese and normal weight adolescents.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2011-09 |
| Est. Completion | 2014-06 |
What the finished NCT01988454 record still lists
NCT01988454 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01988454 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01988454 about?
NCT01988454 is a clinical study titled "Characterization of Dyslipidemia in Adolescent Obesity". The primary objective of this pilot study is to characterize the profile of lipoprotein, inflammatory, and metabolic markers of cardiovascular disease in obese adolescents as compared to normal-weight age-matched controls.
What is the current status of trial NCT01988454?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2011-09. Estimated completion is 2014-06.
Who is sponsoring clinical trial NCT01988454?
This trial is sponsored by Health Diagnostic Laboratory, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia